Equivalent Blood Pressure Reduction and Tolerability with Controlled-Release Metoprolol 50mg Once Daily and Conventional Metoprolol 50mg Twice Daily: A Double-Blind 8-Week Comparison in Hypertensive Patients

Clinical Drug Investigation

Volumn 11, Issue 6, 1996, Pages 331-338

  Scholze, J ^a,c   Klein, G ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Hohenried Clin Cardiovasc Dis   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLD SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRUG TOLERABILITY; EXTRASYSTOLE; FATIGUE; FEMALE; HEADACHE; HEART RATE; HUMAN; HYPERTENSION; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TINGLING; SLEEP DISORDER; STANDING; SUPINE POSITION; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE; VERTIGO;

EID: 0030008926     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199611060-00003     Document Type: Article

References (26)

1. Zanchelti A, Chalmers JP, Arakawa, K et al. The 1993 guidelines for the management of mild hypertension, memorandum from a WHO/ISH meeting. Blood Press 1993; 2: 86-100
2. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNCV). National High Blood Pressure Education Program, 1992
3. MacMahon SW, Cutter JA, Neaton JD, et al. Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. J Hypertens 1986; 4Suppl. 6: 14-7
4. Irving GB, Kerr F, Ewing DJ, et al. Value of prolonged recording of blood pressure in assessment of hypertension. Br Heart J 1974; 36: 859
5. Pullar T, Birtwell AJ, Wiles PG, et al. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988; 44: 540-5
6. Sandberg A, Blomqvist I, Jonsson U, et al. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets. Eur J Clin Pharmacol 1988; 33 Suppl.: 9-14
7. Abrahamsson B, Lücker P, Olofsson B, et al. The relationship between metoprolol plasma concentration and beta1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/Zok formulations. J Clin Pharmacol 1990; 30 Suppl.: 46-54
8. Chen M-F, Yang C-Y, Chen W-J, et al. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension. Cardiovasc Drugs Ther 1995; 9: 401-6
9. Lee Y-T, Liau C-S, Wong ECK, et al. Pharmacokinetic and pharmacodynamic comparison of conventional and controlled release formulations of metoprolol in healthy Chinese subjects. Cardiovasc Drugs Ther 1989: 3: 529-33
10. Scholz M, Schoel G, Schrader J, et al. Antihypertensive Wirkung von α- und β-Blockern in der 24-Stunden-Langzeitblutdruckmessung. Nieren Hochdruckkr 1992; 21: 521-3
11. Benesch L, Neue Metoprolol-Galenik ermöglicht Dosis-reduzierung. Therapiewoche 1991; 41: 1103-6
12. Krönig B, Bedeutung der Galenik für die 24-h-Blutdruckkontrolle. Z Kardiol Angiol Klinik Praxis 1990; 6: 224-9
13. Walle P-O. Westergren G, Dimenäs E, et al. Effects of 100mg controlled-release metoprolol and 100mg atenolol on blood pressure, central nervous system-related symptoms, and general well being. J Clin Pharmacol 1994; 34: 742-7
14. Klein G, Berger J, Olsson G, et al. A double-blind comparison of metoprolol CR/ZOK 50mg and atenolol 50mg once daily for uncomplicated hypertension. J Clin Pharmacol 1990; 30: S72-S77
15. Omvik P, Leer J, Istad H, et al. Equal efficacy and improved tolerability with 50mg controlled-release metoprolol compared with 100mg conventional metoprolol in hypertensive patients. Am J Ther 1994; 1: 65-73
16. Westergren G, Olofsson B, Parlevliet K. Effective once-daily treatment of hypertension with low-dose, controlled-release metoprolol. Curr Ther Res 1994; 55: 142-8
17. Wieselgren I, Lundborg P, Sandberg A, et al. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled-release (CR/Zok) 50mg in young subjects. J Clin Pharmacol 1990; 30 Suppl.: 28-32
18. Materson BJ, Domenic JR, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-21
19. Philipp Th, Holzgreve H, Anlauf A, et al. Efficacy, safety and quality of life in a long-term antihypertensive comparative study. Results of HANE. 19th Meeting of the Scientific Section of the German Hypertension League. Potsdam, 1995 [personal communication]
20. Kendall M. Are selective beta-adrenoceplor blocking drugs an advantage? J R Coll Physicians Lond 1981; 15: 33-40
21. McDevitt D. Clinical significance of cardioselcctivity: state-of-the-art. Drugs 1983; 25 Suppl. 2: 219-26
22. 2-adrenoceptors in the circulating plasma. J Clin Pharmacol 1993; 33: 959-66
23. 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly. Cardiovasc Drugs Ther 1993; 7: 839-49
24. 1-selectivity of conventional metoprolol and metoprolol CR during exercise in healthy volunteers. J Clin Pharm Ther 1993; 18: 259-66
25. Head A, Maxwell S, Kendall MJ, et al. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/ZOK, and placebo. Br J Clin Pharmacol 1994; 38: 499-504
26. Löfdahl C-G, Dahlöf C, Westergren G, et al. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbulaline. Eur J Clin Pharmacol 1988; 33 Suppl.: S25-S32